---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-018697"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T12:14:46.715933+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sangamo Therapeutics raises ~$23M in underwritten public offering of common stock and warrants

## Summary
- Offering of 12.2M shares and pre-funded warrants for 34.4M shares, each with accompanying purchase warrant, at $0.50 unit price.
- Gross proceeds expected ~$23M, before underwriting discounts and expenses; closing expected May 14, 2025.
- Pre-funded warrants exercisable at $0.01 per share; purchase warrants at $0.75 per share, exercisable after six months for six years.
- Sangamo may force exercise of purchase warrants if stock price exceeds $2.75 for ten consecutive trading days after six months.

## SEC filing metadata
- accession: 0001140361-25-018697
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000114036125018697/0001140361-25-018697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000114036125018697/ny20048472x3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-018697
- JSON: https://secwatch.observer/filing/0001140361-25-018697.json
- Plain text: https://secwatch.observer/filing/0001140361-25-018697.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.